What is Torrent Pharmaceuticals Ltd. Quarterly Revenue?

Torrent Pharmaceuticals Ltd. Quarterly Revenue Torrent Pharma Sep-2026 Quarterly Revenue is Rs 4,134 Cr which is growth of 51.2% YoY.

What is Torrent Pharmaceuticals Ltd. Quarterly Net Profit?

Torrent Pharmaceuticals Ltd. Quarterly Net Profit Torrent Pharma Sep-2026 Quarterly Net Profit is Rs 498 Cr which is growth of -16.6% YoY.

What is Torrent Pharmaceuticals Ltd. Annual Revenue?

Torrent Pharmaceuticals Ltd. Annual Revenue Torrent Pharma Mar-2026 Annual Revenue is Rs 10,730 Cr which is growth of 10.5% YoY.

What is Torrent Pharmaceuticals Ltd. Annual Net Profit?

Torrent Pharmaceuticals Ltd. Annual Net Profit Torrent Pharma Mar-2026 Annual Net Profit is Rs 2,192 Cr which is growth of 16.1% YoY.

What is Torrent Pharmaceuticals Ltd. Total Shareholders Fund?

Torrent Pharmaceuticals Ltd. Total Shareholders Fund Torrent Pharma Mar-2026 Total Shareholders Fund is Rs 8,452 Cr which is growth of 11.3% YoY.

What is Torrent Pharmaceuticals Ltd. Total Assets?

Torrent Pharmaceuticals Ltd. Total Assets Torrent Pharma Mar-2026 Total Assets is Rs 25,814 Cr which is growth of 101.0% YoY.

What is Torrent Pharmaceuticals Ltd. Book Value Per Share?

Torrent Pharmaceuticals Ltd. Book Value Per Share Torrent Pharma Mar-2026 Book Value Per Share is 250 Rs which is growth of 11.3% YoY.

What is Torrent Pharmaceuticals Ltd. ROE?

Torrent Pharmaceuticals Ltd. ROE Torrent Pharma Mar-2026 ROE is 26% which is growth of 1.1% YoY.

What is Torrent Pharmaceuticals Ltd. Cash From Operating Activity?

Torrent Pharmaceuticals Ltd. Cash From Operating Activity Torrent Pharma Mar-2026 Cash From Operating Activity is Rs 2,731 Cr which is growth of 6.1% YoY.

What is Torrent Pharmaceuticals Ltd. Net Cash Flow?

Torrent Pharmaceuticals Ltd. Net Cash Flow Torrent Pharma Mar-2026 Net Cash Flow is Rs -34 Cr which is growth of -68180.0% YoY.

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420

Expensive Performer

Download real time

ANDA Approvals

-57.20(-1.21%)

265.9K

NSE+BSE Volume

NSE 13 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Torrent Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Torrent Pharma share price target, revenues, EPS, net income and more

Torrent Pharma quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Torrent Pharma Sep-2026 Quarterly Revenue is Rs 4,134 Cr which is growth of 51.2% YoY.
NEGATIVE
Quarterly Net Profit Torrent Pharma Sep-2026 Quarterly Net Profit is Rs 498 Cr which is growth of -16.6% YoY.

Torrent Pharmaceuticals Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Sep '26	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23
TOTAL_SR_Q Total Rev. ⌄	4,134	4,137	2,793	2,591	2,735	2,611	2,448	2,380	2,427	2,459	2,219	2,112	2,161
SR_Q Operating Rev.	4,145	4,158	2,735	2,599	2,762	2,616	2,433	2,377	2,434	2,438	2,143	2,123	2,146
OI_Q Other Income	-11	-21	58	-8	-27	-5	15	3	-7	21	76	-11	15
OEXPNS_Q Operating Exp.	2,574	2,585	1,732	1,599	1,690	1,637	1,565	1,490	1,513	1,539	1,427	1,422	1,410
OEXPNS_Q Operating Exp.	2,574	2,585	1,732	1,599	1,690	1,637	1,565	1,490	1,513	1,539	1,427	1,422	1,410
OP_Q Operating Profit	1,571	1,573	1,003	1,000	1,072	979	868	887	921	899	716	701	736
OPMPCT_Q Operating Profit Margin %	37.90%	37.83%	36.67%	38.48%	38.81%	37.42%	35.68%	37.32%	37.84%	36.87%	33.41%	33.02%	34.30%
DEP_Q Depr.	587	575	197	191	189	187	190	191	190	189	195	191	192
INT_Q Interest	287	293	225	34	37	45	47	48	54	64	67	69	77
PBT_Q Profit Before Tax	676	663	592	757	806	742	622	651	670	667	530	430	482
TAX_Q Tax	178	171	125	180	209	191	148	166	210	198	120	133	155
NP_Q Net Profit	498	492	467	577	597	551	474	485	460	469	410	297	327
EPS_adj_Q EPS Adj. latest	13.1	12.9	12.3	15.2	15.7	14.5	12.5	12.8	12.1	12.3	10.8	7.8	8.6
NP_TTM Net profit TTM	2,034	2,133	2,192	2,199	2,107	1,970	1,888	1,824	1,636	1,503	1,357	1,166	1,098
EPS_TTM Basic EPS TTM	53.5	63	64.8	65	62.3	58.2	55.8	53.9	48.3	44.4	40.1	34.5	32.4
earnings_transcripts Earnings Transcripts
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Torrent Pharma competitor comparison and performance snapshot within industry

Torrent Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Torrent Pharma Mar-2026 Annual Revenue is Rs 10,730 Cr which is growth of 10.5% YoY.
POSITIVE
Annual Net Profit Torrent Pharma Mar-2026 Annual Net Profit is Rs 2,192 Cr which is growth of 16.1% YoY.

Torrent Pharmaceuticals Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	11.3%	10.3%	13,655	10,729.9	9,713.9	8,624.3	7,777.1	6,946.5	6,568.9	6,405.4	6,144.4	4,580.6	4,892.3	5,732.6
TotalOperatingRevenues_A Operating Rev. Ann.	11.7%	10.7%	13,637	10,712	9,682.4	8,532.9	7,695.2	6,742.3	6,450.6	6,168.4	5,762.5	4,248.2	4,592.7	5,439.5
OI_A Other Income Ann.	-39.8%	-31.5%	18	17.9	31.5	91.4	81.9	204.2	118.3	236.9	382	332.3	299.6	293.1
OEXPNS_A Operating Exp. Ann.	8.4%	9.4%	8,490	6,658.8	6,106.7	5,643.6	5,230	4,641.6	4,258.8	4,251.5	4,149.5	3,340.9	3,465.5	2,798.2
OEXPNS_A Operating Exp. Ann.	8.4%	9.4%	8,490	6,658.8	6,106.7	5,643.6	5,230	4,641.6	4,258.8	4,251.5	4,149.5	3,340.9	3,465.5	2,798.2
OP_A Operating Profit Ann.	18%	13.1%	5,147	4,053.2	3,575.8	2,889.3	2,465.2	2,100.8	2,191.7	1,917	1,613	907.4	1,127.2	2,641.3
OPMPCT_A OPM Ann. %	6%	2.5%		37.77%	36.81%	33.50%	31.70%	30.24%	33.37%	29.93%	26.25%	19.81%	23.04%	46.07%
TotalExpenses_A Total Exp. Ann. ⌄	7.8%	8.3%		7,763.3	7,079.6	6,707.7	6,200.1	5,480.3	5,202.8	5,288.6	5,209.3	4,018.4	3,937.3	3,191.5
OtherExpenses_A Other Exp. Ann.	10.3%	10.6%	3,175	2,467	2,229.4	2,061.2	1,839.4	1,636.1	1,492.1	1,552.2	1,590.7	1,399.1	1,380.1	1,043.4
EmployeeBenefitExpenses_A Employee Exp. Ann.	14.5%	11.4%	2,312	1,879.4	1,636.5	1,450.7	1,251.2	1,097.9	1,097.1	1,061.8	1,014.1	826.1	699	572.1
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	16.9%	12%		4,071.1	3,607.3	2,980.7	2,547	2,304.9	2,310.1	2,153.9	1,995	1,239.7	1,426.8	2,934.4
EBIDTPCT_A EBITDA Ann. margin %	5%	1.5%		37.94%	37.13%	34.56%	32.75%	33.18%	35.17%	33.63%	32.47%	27.06%	29.16%	51.19%
INT_A Interest Ann.	4.6%	0.4%	839	341	213.4	303	297.7	236.3	334.1	430.5	481	293.7	202.4	179.8
DEP_A Depr.	4.3%	4.6%	1,550	763.5	759.5	761.1	672.3	602.4	609.8	606.7	578.9	383.9	269.4	213.4
PBT_A PBT Ann.	22.5%	16.2%	2,688	2,896.6	2,610.2	1,916.6	1,577	1,466.2	1,366.1	1,116.8	935.1	562.1	955	2,348.4
TAX_A Tax Ann.	10.3%	25.3%	654	705	722.1	559.5	525.6	474.8	228.3	178.3	189.7	80.1	100.8	605.4
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	27.7%	14%		2,191.6	1,888.1	1,357.1	1,051.4	991.5	1,137.9	938.5	745.4	482	854.2	1,743
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	27.7%	14%	2,034	2,191.6	1,888.1	1,357.1	1,051.4	991.5	1,137.9	938.5	745.4	482	854.2	1,743
NETPCT_A NPM Ann. %	14.4%	3%		20.45%	19.49%	15.90%	13.66%	14.70%	17.63%	15.21%	12.93%	11.34%	18.59%	32.04%
EPS_adj_A EPS Adj. latest Ann.	27.8%	14%		57.6	49.6	35.7	27.6	26.1	29.9	24.7	19.6	12.7	22.5	45.8
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

10.5%

2Y CAGR

11.5%

3Y CAGR

11.3%

5Y CAGR

10.3%

7Y CAGR

8.3%

10Y CAGR

6.5%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

16.1%

2Y CAGR

27.1%

3Y CAGR

27.7%

5Y CAGR

14%

7Y CAGR

16.7%

10Y CAGR

2.3%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

2Y CAGR

8.6%

3Y CAGR

8.4%

5Y CAGR

9.4%

7Y CAGR

10Y CAGR

9.1%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Torrent Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Torrent Pharma Mar-2026 Total Shareholders Fund is Rs 8,452 Cr which is growth of 11.3% YoY.
POSITIVE
Total Assets Torrent Pharma Mar-2026 Total Assets is Rs 25,814 Cr which is growth of 101.0% YoY.

Torrent Pharmaceuticals Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	9.4%	7%	8,452.2	7,592.5	6,828.8	6,456	6,345.4	6,030.1	5,121	5,015.3	4,556.5	4,453.7	3,707.3
EQCAP_A Equity Share Capital Ann.	0%	14.9%	169.2	169.2	169.2	169.2	84.6	84.6	84.6	84.6	84.6	84.6	84.6
TotalShareCapital_A Total Share Capital Ann.	0%	14.9%	169.2	169.2	169.2	169.2	84.6	84.6	84.6	84.6	84.6	84.6	84.6
ReservesAndSurplus_A Reserves Plus Surplus Ann.	9.6%	6.9%	8,282.9	7,423.3	6,659.5	6,286.7	6,260.8	5,945.5	5,036.4	4,930.7	4,471.9	4,369.1	3,622.7
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	9.6%	6.9%	8,282.9	7,423.3	6,659.5	6,286.7	6,260.8	5,945.5	5,036.4	4,930.7	4,471.9	4,369.1	3,622.7
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	62%	32.4%	12,772.5	2,269.6	2,559.2	3,006.8	2,383.8	3,145.1	3,376	3,924.2	4,276	2,442.7	2,079.3
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	23.9%	-	763.6	828.5	655.8	401.3	193.6			7.5		100.7	171.3
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	83%	77.7%	178.9	82.8	17.5	29.2	7.8	10.1	74.9	12.9	15.5	6.9	9
CL_A Total Current Liabilities Ann. ⌄	10.4%	12.2%	4,588.8	2,979.6	2,988.6	3,409.2	2,423.4	2,585.8	3,387.5	3,087.8	2,987.6	1,154.5	1,502
TradePayables_A Trade Payables Ann.	9.7%	4.5%	805.8	767.1	759.8	610.6	624.2	648.1	682.1	582.3	775.7	548	665.2
OtherCurrentLiabilities_A Other Current Liabilities Ann.	27.7%	17.3%	862.3	478.8	328.9	414.1	307	387.6	1,822.3	1,694.8	1,091.6	551.2	789.8
ShortTermProvisions_A ST Provisions Ann.	13.2%	15.4%	218.5	207.5	170.7	150.6	120.3	106.8	93.8	84.1	80.1	55.4	47
TL_A Total Capital Plus Liabilities Ann.	26.1%	17%	25,813.5	12,841.8	12,376.6	12,871.9	11,152.6	11,761	11,884.5	12,027.3	11,820.1	8,050.9	7,288.5
FixedAssets_A Fixed Assets Ann. ⌄	-3.5%	1.2%	7,790.1	7,955.9	8,212.2	8,669.8	6,818.8	7,329.4	7,733.9	7,922.7	7,875.9	3,996.6	3,665.1
TangibleAssets_A Tangible Assets Ann.	7.5%	4%	3,336.3	3,131.4	3,205	2,687.5	2,619.4	2,745.3	2,813.2	2,673.3	2,299.3	1,832.9	943.8
IntangibleAssets_A Intangible Assets Ann.	-8.7%	0.1%	4,020.8	4,422.7	4,781	5,284.4	3,631.9	3,995.9	4,384.4	4,751.9	5,129.3	1,690.6	1,737.6
CapitalWorkInProgress_A Capital Work In Progress Ann.	-17.1%	-7.1%	384.3	365.6	203.9	674.9	543.5	554.8	513.3	470.9	422.8	462.4	983.7
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	32.7%	22.4%	20,921.3	8,493	8,635.5	8,944.9	7,092.5	7,619.2	8,065.2	8,278.3	8,180.9	4,505.3	4,150.7
NonCurrentInvestments_A Non Current Investments Ann.	299.2%	136.9%	13,045.5	410.5	322.3	205.1	183.7	174.9	134.9	134.9	149.8	148.4	153.9
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-						28.3	67.8		0.8
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	8.6%	9.9%	3.2	3.4	2.5	2.5	1.8	2	2.3	2.6	2.5	108.8	151.7
OtherNonCurrentAssets_A Other Non Current Assets Ann.	7%	-0.5%	82.6	123.2	98.6	67.5	88.4	84.6	126.4	218.1	151.9	251.5	180
CA_A Total Current Assets Ann. ⌄	7.6%	3.4%	4,892.2	4,348.8	3,741.1	3,927.1	4,060.1	4,141.9	3,819.3	3,749	3,639.1	3,545.5	3,137
CurrentInvestments_A Current Investments Ann.	-6.7%	-1.8%	126.8	112.2	141	156.1	184	139.1	0	351.4	475.2	787.4	764.2
TradeReceivables_A Trade Receivables Ann.	15.2%	11.3%	2,641.1	2,170.8	1,571.9	1,729.4	1,541.4	1,544.3	1,508.9	1,356	1,108	1,018.5	911.5
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-17.5%	4.6%	83	109.7	108.8	147.6	69.5	66.4	391	237.8	57.1	78.2	82.4
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	41.3%	9.1%	4.8	4.2	3.1	1.7	2.6	3.1	3.6	3.8	110.1	42.7	40.2
OtherCurrentAssets_A Other Current Assets Ann.	20.7%	1.4%	510.4	391	350.7	290	465.5	477.3	408	441.7	589.2	586.5	369.4
TA_A Total Assets Ann.	26.1%	17%	25,813.5	12,841.8	12,376.6	12,871.9	11,152.6	11,761	11,884.5	12,027.3	11,820.1	8,050.9	7,288.5
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	1.8%	5.7%	1,527.4	1,369	1,395.4	1,449	1,296.4	1,155.4	325.4	374.9	313.5	394.4	343
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	15.9%	162.4	162.4	162.4	162.4	77.8	77.8	77.8	77.8	77.8	77.8	77.8
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	35.3%	23.8%	508.2	410.5	322.3	205.1	183.7	174.9	134.9	134.9	149.8	148.4	153.9
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-					184	139.1		351.4	475.2	787.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

101%

2Y CAGR

44.4%

3Y CAGR

26.1%

5Y CAGR

17%

7Y CAGR

11.5%

10Y CAGR

13.5%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

54%

2Y CAGR

23.9%

3Y CAGR

10.4%

5Y CAGR

12.2%

7Y CAGR

5.8%

10Y CAGR

11.8%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

11.3%

2Y CAGR

11.3%

3Y CAGR

9.4%

5Y CAGR

7Y CAGR

7.7%

10Y CAGR

8.6%

Total ShareHolders Funds Annual growth is higher than historical averages.

Torrent Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Torrent Pharma Mar-2026 Book Value Per Share is 250 Rs which is growth of 11.3% YoY.
POSITIVE
ROE Torrent Pharma Mar-2026 ROE is 26% which is growth of 1.1% YoY.

Torrent Pharmaceuticals Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	9.4%	-6.9%	249.7	224.3	201.8	190.7	374.9	356.3	302.6	296.3	269.2	263.2	219.1
ROA_A RoA Ann. %	1.3%	-2.6%	8.49%	14.70%	10.96%	8.16%	8.88%	9.67%	7.89%	6.19%	4.07%	10.61%	23.91%
ROE_A ROE Ann. %	16.8%	6.6%	25.92%	24.86%	19.87%	16.28%	15.62%	18.86%	18.32%	14.86%	10.57%	19.17%	47.01%
ROCE_A ROCE Ann. %	-7.7%	-3.4%	15.58%	28.87%	23.64%	19.81%	19.50%	18.53%	18.20%	15.84%	9.68%	16.78%	47.02%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	4.7%	1.2%	38.00%	37.25%	34.93%	33.09%	34.18%	35.81%	34.91%	34.62%	29.18%	31.06%	53.94%
PBITMargin_A EBIT Ann. Margin %	8.2%	3.2%	30.87%	29.41%	26.01%	24.36%	25.25%	26.35%	25.08%	24.57%	20.14%	25.20%	50.02%
PBTMargin_A PBT Ann. Margin %	9.7%	5%	27.04%	26.95%	22.46%	20.49%	21.74%	21.17%	18.10%	16.22%	13.23%	20.79%	43.17%
NETPCT_A NPM Ann. %	14.4%	3%	20.45%	19.49%	15.90%	13.66%	14.70%	17.63%	15.21%	12.93%	11.34%	18.59%	32.04%
ASETTO_A Asset Turnover Ann. %	0%	0%	0.6	0.8	0.7	0.6	0.6	0.6	0.5	0.5	0.4	0.6	0.8
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-2.9%	-7.2%	1.1	1.5	1.3	1.2	1.7	1.6	1.1	1.2	1.2	3.1	2.1
QuickRatio_A Quick Ratio Ann.	0%	-4.9%	0.7	0.9	0.7	0.7	0.9	0.9	0.7	0.8	0.8	2.2	1.4
DividendPayoutNP_A Dividend Payout to NP Ann.	-12.6%	-3%	0.6	0.6	0.8	0.9	1.5	0.7	1.5	0.9	1	0.5	0.9
EarningRetention_A Earning Retention Ann. %	36.9%	-8.1%	45.95%	42.64%	25.19%	17.92%	31.73%	70.26%	35.09%	59.14%	54.37%	80.20%	59.96%
CashEarningRetention_A Cash Earning Retention Ann. %	6.3%	-5.8%	59.92%	59.10%	52.07%	49.94%	57.54%	80.64%	60.58%	77.00%	74.60%	84.94%	64.33%
CashEarningRetention_A Cash Earning Retention Ann. %	6.3%	-5.8%	59.92%	59.10%	52.07%	49.94%	57.54%	80.64%	60.58%	77.00%	74.60%	84.94%	64.33%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	40.6%	27.1%	156,933.2	111,915.4	91,262.7	56,451.1	50,598.5	47,325.3	36,888.5	37,267.8	26,214	28,350	24,375
EVPerNetSales_A EV Per Net Sales Ann.	26.3%	15%	14.7	11.6	10.7	7.3	7.5	7.3	6	6.5	6.2	6.2	4.5
PBV_A Price To Book Value Adjusted	-5%	9.8%	20.96	21	23.15	24.48	12.46	13.11	15.44	15.76	17.35	17.83	21.42
EVPerEBITDA_A EV Per EBITDA Ann.	20.2%	13.5%	38.6	31	30.6	22.2	22	20.5	17.1	18.7	21.2	19.9	8.3
MarketCapPerSales_A Market Cap Per Sales Ann.	25.1%	14.7%	13.3	11.3	10.3	6.8	7	6.7	5.4	5.7	5	5.7	4.2
RetentionRatios_A Retention Ratio Ann. %	36.9%	-8.1%	45.94%	42.63%	25.18%	17.91%	31.72%	70.25%	35.08%	59.13%	54.36%	80.19%	59.95%
EYield_A Earnings Yield Ann.	-	-	0	0	0	0	0	0	0	0	0	0	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	34.4%	19.4%	1.7	0.3	0.5	0.7	0.5	0.7	0.8	0.9	1.1	0.5	0.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

4.3%

2Y CAGR

14.2%

3Y CAGR

16.8%

5Y CAGR

6.6%

7Y CAGR

8.3%

10Y CAGR

-5.8%

ROE Annual % is growing slower than historical averages.

RoA Ann. %

1Y CHG

-42.2%

2Y CAGR

-12%

3Y CAGR

1.3%

5Y CAGR

-2.6%

7Y CAGR

4.6%

10Y CAGR

-9.8%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-26.7%

2Y CAGR

-8%

3Y CAGR

-2.9%

5Y CAGR

-7.2%

7Y CAGR

-1.2%

10Y CAGR

-6.3%

Current Ratio Annual is falling faster than historical averages.

Torrent Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Torrent Pharma Mar-2026 Cash From Operating Activity is Rs 2,731 Cr which is growth of 6.1% YoY.
NEGATIVE
Net Cash Flow Torrent Pharma Mar-2026 Net Cash Flow is Rs -34 Cr which is growth of -68180.0% YoY.

Torrent Pharmaceuticals Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	6.4%	11.6%	2,730.8	2,574.5	2,893.1	2,265.4	2,140.1	1,578.2	1,579.9	1,231.8	941.1	679.4	2,403
PBT_A PBT Ann.	22.5%	16.2%	2,896.6	2,610.2	1,916.6	1,577	1,466.2	1,366.1	1,116.8	935.1	562.1	955	2,348.4
INT_A Interest Ann.	4.6%	0.4%	341	213.4	303	297.7	236.3	334.1	430.5	481	293.7	202.4	179.8
TAX_A Tax Ann.	10.3%	25.3%	705	722.1	559.5	525.6	474.8	228.3	178.3	189.7	80.1	100.8	605.4
CFI_A Cash from Investing Act. Ann.	-	-	-12,990.2	-470.1	-296.1	-2,384.1	-159.7	-316.3	269.4	-373.3	-4,218.9	-532.6	-586.2
CFA_A Cash from Financing Act. Ann.	402.3%	-	10,225.2	-2,104.5	-2,577.6	80.7	-1,977.3	-1,586.5	-1,555.5	-927.6	2,928.7	-131.3	-1,325.8
NCF_A Net Cash Flow Ann. ⌄	-	-	-34.1	-0.1	19.5	-37.9	3.1	-324.6	293.9	-69.1	-349.1	15.5	491
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	17.3%	-23%	104.8	104.9	85.4	65	61.9	386.5	92.6	513	862.1	846.6	353.8
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-6.1%	2.7%	70.7	104.8	104.9	85.4	65	61.9	386.5	443.9	513	862.1	846.6

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

6.1%

2Y CAGR

-2.8%

3Y CAGR

6.4%

5Y CAGR

11.6%

7Y CAGR

12%

10Y CAGR

1.3%

Cash from Operating Activity Annual growth is lower than historical averages.

Cash from Financing Act. Ann.

3Y CAGR

402.3%

Cash from Financing Annual Activity growth is higher than historical averages.

Torrent Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Torrent Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Torrent Pharma - Forecaster

Forecaster Analyst Estimates for Torrent Pharma share price target, revenues, EPS, net income and more